Search research articles
Contact Us
Filters
Showing results (361-370 of 504) with videos related to
Page
of 51
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 10, 2016
Semiquantitative Parameters in PSMA-Targeted PET Imaging with <sup>18</sup>F-DCFPyL: Variability in Normal-Organ Uptake
Xin Li, Steven P Rowe, Jeffrey P Leal, et al.
Nuklearmedizin. Nuclear Medicine
|
January 14, 2022
[18F]DCFPyL PET/CT for Imaging of Prostate Cancer
Steven P Rowe, Andreas Buck, Ralph A Bundschuh, et al.
Radiology
|
March 31, 2021
Prostate-specific Membrane Antigen PET in Prostate Cancer
Courtney Lawhn-Heath, Ali Salavati, Spencer C Behr, et al.
Radiologic Clinics of North America
|
November 16, 2023
Prostate-Specific Membrane Antigen-Ligand Therapy: What the Radiologist Needs to Know
Steven P Rowe, Mohammad S Sadaghiani, Andrei Gafita, et al.
Clinical Nuclear Medicine
|
May 11, 2023
Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System Tumors
Alexander Weich, Sebastian E Serfling, Wiebke Schlötelburg, et al.
Nuklearmedizin. Nuclear Medicine
|
August 17, 2022
Clinical Utility of C-Reactive Protein and White Blood Cell Count for Scheduling an [18F]FDG PET/CT in Patients with Giant Cell Arteritis
Konstanze V Guggenberger, Marius L Vogt, Steven P Rowe, et al.
ACS Chemical Biology
|
April 8, 2009
Amphipathic small molecules mimic the binding mode and function of endogenous transcription factors
Sara J Buhrlage, Caleb A Bates, Steven P Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 16, 2021
Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
Mark C Markowski, Pedro Isaacsson Velho, Mario A Eisenberger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 6, 2021
A bicentric retrospective analysis of clinical utility of <sup>18</sup>F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: is it helpful in patients with a PSA rise less than the Phoenix criteria?
Ali Salavati, Mehmet Gencturk, Yasemin Koksel, et al.
Seminars in Nuclear Medicine
|
November 18, 2023
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging
Andrew F Voter, Rudolf A Werner, Hatice Savas, et al.
Page
of 51
Search research articles
Search
Showing results (361-370 of 504) with videos related to
Sort By:
Page
of 51
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 10, 2016
Semiquantitative Parameters in PSMA-Targeted PET Imaging with <sup>18</sup>F-DCFPyL: Variability in Normal-Organ Uptake
Xin Li, Steven P Rowe, Jeffrey P Leal, et al.
Nuklearmedizin. Nuclear Medicine
|
January 14, 2022
[18F]DCFPyL PET/CT for Imaging of Prostate Cancer
Steven P Rowe, Andreas Buck, Ralph A Bundschuh, et al.
Radiology
|
March 31, 2021
Prostate-specific Membrane Antigen PET in Prostate Cancer
Courtney Lawhn-Heath, Ali Salavati, Spencer C Behr, et al.
Radiologic Clinics of North America
|
November 16, 2023
Prostate-Specific Membrane Antigen-Ligand Therapy: What the Radiologist Needs to Know
Steven P Rowe, Mohammad S Sadaghiani, Andrei Gafita, et al.
Clinical Nuclear Medicine
|
May 11, 2023
Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System Tumors
Alexander Weich, Sebastian E Serfling, Wiebke Schlötelburg, et al.
Nuklearmedizin. Nuclear Medicine
|
August 17, 2022
Clinical Utility of C-Reactive Protein and White Blood Cell Count for Scheduling an [18F]FDG PET/CT in Patients with Giant Cell Arteritis
Konstanze V Guggenberger, Marius L Vogt, Steven P Rowe, et al.
ACS Chemical Biology
|
April 8, 2009
Amphipathic small molecules mimic the binding mode and function of endogenous transcription factors
Sara J Buhrlage, Caleb A Bates, Steven P Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 16, 2021
Detection of Early Progression with <sup>18</sup>F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
Mark C Markowski, Pedro Isaacsson Velho, Mario A Eisenberger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 6, 2021
A bicentric retrospective analysis of clinical utility of <sup>18</sup>F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: is it helpful in patients with a PSA rise less than the Phoenix criteria?
Ali Salavati, Mehmet Gencturk, Yasemin Koksel, et al.
Seminars in Nuclear Medicine
|
November 18, 2023
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging
Andrew F Voter, Rudolf A Werner, Hatice Savas, et al.
Page
of 51